Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed, Previously Untreated Multiple Myeloma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Onyx Therapeutics, Inc.
Celgene Corporation
Information provided by (Responsible Party):
University of Michigan Cancer Center
ClinicalTrials.gov Identifier:
NCT01029054
First received: December 8, 2009
Last updated: October 14, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2016
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)
No publications provided by University of Michigan Cancer Center

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):